Skip to main content

CMOM-HEM/ONC Course: A Valuable Resource for Practice Managers

Web Exclusives - Practice Management
Ina Huang

In the evolving landscape of today’s healthcare industry, more and more demands are being placed on practice managers and their staff. The Certified Medical Office Manager-Business of Hematology & Oncology (CMOM-HEM/ONC) program is a valuable resource for oncology practice managers who want to gain the knowledge and skills they need to motivate their employees, improve their practice’s financial outlook, and handle administrative issues so that providers can focus on maintaining high-quality care for their patients.

In an exclusive interview with Oncology Practice Management (OPM), Mary Kay Makarewicz, Executive Director, Michigan Society of Hematology and Oncology (MSHO), Troy, MI, and Deborah McNeilance, MBA-HCA, CMC, CMIS, CMOM, CPC, Administrator and CEO, Huron Gastro/Center for Digestive Care, Ypsilanti, MI, discussed the benefits of the CMOM-HEM/ONC course, and explained how the curriculum was developed to help professionals become more effective in their oncology practice management roles.

OPM: What led to MSHO’s decision to partner with Practice Management Institute (PMI) to offer the CMOM-HEM/ONC certification course?

Ms Makarewicz: Ms McNeilance became a CMOM in 2008 and has maintained the credential ever since. As a long-time member of MSHO, she knew the value this course would offer our practice managers and other administrative personnel. In reviewing the course materials, I found the curriculum to be very relevant and was impressed with the breadth of information contained in each module. After obtaining further details through discussions with Michael Moore, PMI Vice President of Business Development, the idea was presented to our manager group and the MSHO Board of Directors. Their feedback was extremely positive.

When Ms McNeilance took the CMOM course, it consisted of 5 modules (Practice Management, Personnel Management, Financial Management, Compliance Requirements, and Managed Care Delivery System). These modules, which were developed by PMI, provide a very comprehensive curriculum that is applicable to the needs of practice managers working in any medical specialty.

The 6th module on the Business of Hematology & Oncology was added as a complement to the original CMOM curriculum. The content in this new module, which covers topics such as physician contracting, oral oncolytics and adherence, GPO and pharmaceutical contracting, the 340b drug program, and palliative care and survivorship, was developed by Ms McNeilance. She has also taken on the responsibility of teaching the CMOM-HEM/ONC course to individuals who want to pursue this additional certification.

Since 2016, we have partnered with PMI to offer the CMOM-HEM/ONC certification course in the state of Michigan. This course has been a go-to resource for professionals who want to run a truly efficient and financially healthy oncology practice.

OPM: What was the rationale for developing the HEM/ONC module?

Ms McNeilance: The management of oncology practices has become very complex. I developed the HEM/ONC module so that we could expand the CMOM curriculum to address the unique challenges facing professionals who work in oncology practices. The topics included in this module were chosen to fill unmet needs that were identified through my own experiences as an administrator, as well as val­uable feedback from colleagues and fellow members of MSHO.

For example, we discovered that many managers are not familiar with physician contracting and do not understand the process of putting together a contract. As an administrator in a practice, you need to be aware of the points that the physician recruiter is focusing on to ensure that you are attracting appropriate staff for your office. The identification of this unmet need led to the decision to address the topic of physician contracting in the HEM/ONC module.

We also felt it was important to include a section on oral oncolytics, which are being used more frequently in the treatment of patients with cancer. There are important differences in the way that these newer drugs are handled, coded, and billed compared with traditional infusion drugs, so there is a learning curve that must be addressed.

Additional sections, such as financial toxicity, palliative care and survivorship, and how to use advanced practitioners, are also extremely relevant for oncology practice managers who want to run a state-of-the-art practice.

OPM: Is the CMOM-HEM/ONC course beneficial for seasoned professionals as well as those just starting out as administrators?

Ms McNeilance: I have taught this course to a wide range of professionals, including nursing managers, practice administrators, billing managers, and chief operating officers, many of whom have 20+ years of experience in the field. They have all said that they gained valuable knowledge as a result of taking the course. Many participants have told me that they have gotten a bit off track because they are so busy with the daily demands of running a practice. Taking the course has helped them to stay mindful of responsibilities that may have been placed on the back burner but are critical for running an efficient practice. So, the course is beneficial to all administrators regardless of their level of experience.

Ms Makarewicz: I would also like to mention that the CMOM-HEM/ONC course provides seasoned administrators with valuable information on some of the more recent advances in the field of oncology, such as integration of nurse navigators, and the increased use of oral oncolytics to treat various types of cancer. These are topics that would not have been covered in training that professionals received 10 or 20 years ago when they began their careers.

This course would also be an excellent resource for fellows. During their training, there is, of course, great emphasis placed on clinical knowledge and expertise. However, when oncologists begin practicing in a ­real-world setting, they also need to know how to navigate the business side of a practice, a topic that may not have been addressed extensively during their training. The CMOM-HEM/ONC curriculum can provide them with the information they need to hone these important skills.

OPM: Is there anything else you would like our readers to know about the course?

Ms Makarewicz: We have received positive feedback from our members and plan to continue offering this course to them. We wanted to share this valuable resource with other state societies. That is why this year MSHO sponsored 5 out-of-state oncology administrators (from Alaska, Iowa, Texas, and Washington) to participate in this course (see box for feedback by one of these participants). It is our hope that these administrators will share their experience with their state society leadership and raise awareness of this certification in their states.

PMI currently offers the 5 modules of the CMOM course as an online option, but individuals interested in taking the HEM/ONC module must do so by attending a live session.

Because MSHO sponsors the course for our administrators, we require them to attend live sessions for all the modules, which allows for more interaction among participants as they work through the curriculum.

Ms McNeilance is working with PMI to create an online version of the HEM/ONC course. The goal is to have this available for participants sometime in 2020.

“I can’t say enough about the professionalism from PMI during my path to excellence in becoming a CMOM. While I am happy that MultiCare Regional Cancer Center is part of a large healthcare organization, learning the components of the course has helped me to appreciate all that goes into managing a practice. I have used the education component of the program daily in my leadership role and am so appreciative to PMI for creating such an organized course. Although I will be the first in the state of Washington to obtain the CMOM-HEM/ONC certification, I am certainly talking it up to other leaders within my organization and I look to lead the way for many CMOMs to come.”

–Alicia Duvall, RN, CMOM

Related Items
Artificial Intelligence and the Future of Healthcare
Fop Johnson
Web Exclusives in Practice Management
Artificial intelligence tools and applications have shown great promise in delivering higher quality healthcare, but current offerings are at various stages of maturity and capability and are not yet in widespread use.
The Flaw in Infusion Scheduling
Web Exclusives in Practice Management
In reality, scheduling appointments with significant lead times, often weeks or months before the actual appointment, may actually cause more problems and serve fewer patients.
Applying Business Principles to Everyday Practice
Meg Barbor, MPH
Web Exclusives in Practice Management
Given the high cost of oncology drugs, it is important for pharmacists to become more business savvy regarding their practices.
Identifying the Problem Is Key to Quality Improvement in Cancer Care
Meg Barbor, MPH
Web Exclusives in Practice Management
“There are a number of ways to go wrong when you’re trying to improve something,” said Kaveh G. Shojania, MD, Director, Centre for Quality Improvement and Patient Safety, University of Toronto, Canada, and Editor-in-Chief, BMJ Quality & Safety, who delivered the keynote address at the 2018 ASCO Quality Care Symposium.
FDA Perspective: Reducing Cost, Increasing Access to Cancer Care
Chase Doyle
Web Exclusives in Practice Management
In a time when the country feels more politically divided than ever, there is broad consensus that Medicare should be allowed to negotiate prescription drug prices directly with drug makers, and that the FDA should expedite approvals of generic cancer drugs to lower patients’ out-of-pocket costs.
One Oncologist’s Firsthand Experience with Serious Illness: What Your Patients Want
Meg Barbor, MPH
Web Exclusives in Practice Management
There’s really only one way to identify how patients are coping with serious illness: by asking them, according to Thomas J. Smith, MD, FACP, Director of Palliative Medicine, Johns Hopkins Medical Institutions, Baltimore, MD.
Harnessing the Power of Data Collection and Coordination in Oncology Practice
Meg Barbor, MPH
Web Exclusives in Practice Management
Business intelligence is the process of collecting data from disparate systems—internal and external—and turning it into information that is meaningful and actionable toward achieving strategic goals.
MIPS: How to Be Successful Today and in the Future
Toni Gress
Web Exclusives in Practice Management
The McKesson value-based care team employs a combination of tactics to help practices in The US Oncology Network achieve success in the Merit-Based Incentive Payment System (MIPS). One of the challenges with the new MIPS program is the need to focus on the current year’s performance, while taking steps to ensure that practices are successful in future years.
Oncology Practice Landscape in 2018: ASCO Survey Shows Interactions with Payers Top Concern
Eileen Koutnik-Fotopoulos
Web Exclusives in Practice Management
Oncology practices are challenged by day-to-day operational functions, which are often related to payment, reimbursement, and competition, according to the new survey titled “The State of Oncology Practice in America” from the American Society of Clinical Oncology (ASCO) on the oncology practice landscape in the United States.
FDA Commissioner Outlines New Plan to Increase Biosimilars by “Balancing Innovation and Competition”
Eileen Koutnik-Fotopoulos
Web Exclusives in Practice Management
FDA Commissioner Scott Gottlieb, MD, has been outspoken about the critical need to reign in drug prices. Biosimilars are crucial for improving patient access to biologic drugs at an affordable cost. Biologics are now key in the treatment of cancer and autoimmune conditions. But cost remains an obstacle to access to drug therapy.
Last modified: June 11, 2020